Telix Pharmaceuticals Publishes TLX250-Px Kidney Study
Melbourne, Australia and Indianapolis, IN, United States – May 5, 2026 Telix Pharmaceuticals Limited has announced the publication of...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Ophthalmology Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Melbourne, Australia and Indianapolis, IN, United States – May 5, 2026 Telix Pharmaceuticals Limited has announced the publication of...
CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...
RAHWAY, N.J., Feb. 12, 2026 — Merck & Co. announced the presentation of extensive new clinical data in bladder...
